Brief: Landos Biopharma To Present Two Late-Breaking Presentations On Therapeutic Potential Of Omilancor And Px-69 At The 2021 American Association Of Immunologists (Aai) Annual Meeting
26/04/2021 14:12
April 26 (Reuters) - Landos Biopharma Inc LABP.O :
* LANDOS BIOPHARMA TO PRESENT TWO LATE-BREAKING
PRESENTATIONS ON
THERAPEUTIC POTENTIAL OF OMILANCOR AND PX-69 AT THE 2021
AMERICAN ASSOCIATION OF IMMUNOLOGISTS (AAI) ANNUAL MEETING
Source text for Eikon: ID:nGNX2jv1Gx
Further company coverage: LABP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma